subject predicate object context
18206 Creator 0e2d1b90682e8c08761586c8975c7f13
18206 Creator 538c0722d7d106c7098d06ea38e69498
18206 Creator ext-98d68f4cec4e55e0b4b3ecb383a1845d
18206 Creator ext-2bdc2db59d14fe556fa4dd2273cd078d
18206 Creator ext-d60c5f331dbc14edd9caa8f7d609567d
18206 Creator ext-7765010057f3364f4dc1e5c9b60e5eb6
18206 Creator ext-c61147ac66f6533e2441c4e0fc0d78a4
18206 Creator ext-e77701564cc64b76e76376562cf6879e
18206 Creator ext-0000d06d55992004182d4d3325c6ee36
18206 Creator ext-70e72b5d9c3666c5ef0a1ccf16ad72a5
18206 Date 2005-08
18206 Is Part Of repository
18206 Is Part Of p13652036
18206 abstract <b>Background:</b>A 15-fold increased risk of gastrointestinal bleeding has been reported with concurrent use of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Recent guidance cautions against concurrent prescription, particularly in older people.<br></br><br></br><b> Aim:</b> To quantify the risk of gastrointestinal bleeding associated with current exposure to non-steroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors, and both drugs concurrently.<br></br><br></br><b> Methods:</b> We conducted a case-control analysis of 11 261 cases with upper gastrointestinal bleeding and 53 156 controls matched by gender, age and general practice from computerized primary care data. We coupled this with self-controlled case series analysis. <br></br><br></br><b>Results:</b> Both drugs were associated with a twofold increased risk of gastrointestinal bleeding (odds ratio =2.38, 95% confidence interval 2.08-2.72 for selective serotonin reuptake inhibitors and odds ratio = 2.15, 95% confidence interval 2.02-2.28 for non-steroidal anti-inflammatory drugs). This increased risk was marginally higher for concurrent prescription (odds ratio = 2.93, 95%confidence interval 2.25-3.82). The self-controlled analysis showed a greater incidence rate ratio for gastrointestinal bleeding with non-steroidal anti-inflammatory drugs (2.71, 95% confidence interval 2.51-2.91) and lower incidence rate ratio with selective serotonin reuptake inhibitors (1.71, 95% confidence interval 1.48-1.98). The incidence rate ratio when both drugs were combined was 3.25, 95% confidence interval 1.95-5.42. Estimates were similar after restricting to people over 80 years of age. Increased risk of gastrointestinal bleeding was not specifically related to class of non-steroidal anti-inflammatory drugs and was similar when we looked at tricyclic anti-depressants. <br></br><br></br><b>Conclusions:</b> Our study suggests that the risk of gastrointestinal bleeding is not substantially increased when non-steroidal anti-inflammatory drugs and selective serotonin reuptake inhibitors are prescribed together, compared with their use alone.
18206 authorList authors
18206 issue 3
18206 status peerReviewed
18206 volume 22
18206 type AcademicArticle
18206 type Article
18206 label Tata, L. J.; Fortun, P. J.; Hubbard, R. B.; Smeeth, L.; Hawkey, C. J.; Smith, C. J. P.; Whitaker, H. J. ; Farrington, C. P. ; Card, T. R. and West, J. (2005). Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Alimentary Pharmacology & Therapeutics, 22(3) pp. 175–181.
18206 label Tata, L. J.; Fortun, P. J.; Hubbard, R. B.; Smeeth, L.; Hawkey, C. J.; Smith, C. J. P.; Whitaker, H. J. ; Farrington, C. P. ; Card, T. R. and West, J. (2005). Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Alimentary Pharmacology & Therapeutics, 22(3) pp. 175–181.
18206 Title Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
18206 in dataset oro